Public consultation on the use of a genetically modified organism in a clinical trial

The Federal Public Service Health, Food Chain Safety and Environment and the Federal Agency for Medicines and Health Products inform you of a clinical trial with a genetically modified medicine from BN Immuno Therapeutics for fighting prostate cancer. The public consultation on this trial will run from April 20th to May 20th 2012 inclusive.

See other languages: French or Dutch

 

Last updated on
08/05/2012